{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:09:33Z","timestamp":1778735373645,"version":"3.51.4"},"reference-count":33,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019211","name":"AbbVie Canada","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100019211","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Objectives: To investigate current Canadian physicians\u2019 practice patterns of treating upper limb post-stroke spasticity (PSS) and hemiplegic shoulder pain (HSP) acutely after a stroke. In addition, by examining Canadian physicians\u2019 diagnostic capabilities, time till treatment, minimum criteria to begin treatment, mechanisms of treatment, targeting of muscles, and benefits and adverse effects of treatment, we aim to learn about areas of improvement to optimize PSS management for Canadians. Design: The present study was a cross-sectional survey, polling practicing Canadian physicians. Results: A total of 17 physicians completed the survey, all PM&amp;R specialists, save one neurologist. Four provinces were represented in the responses. Participants had, on average, over ten years of experience managing post-stroke spasticity in outpatient and inpatient clinics. All 17 perform botulinum neurotoxin A (BoNT-A) injections for HSP associated with PSS. Most participants reported that they will begin BoNT-A treatments 2\u20133 weeks post-stroke, most commonly targeting the pectoralis major, subscapularis, and latissimus dorsi. Participants reported the mean median dosage they use as onabotulinum toxin A (169.12 units, SD = 73.70), incobotulinum toxin A (178.13 units, SD = 65.75), and abobotulinum toxin A (470.83 units, SD = 171.17). For injection guidance, participants responded that they use ultrasound for the largest percentage of their caseload, followed by electromyography, then electrical stimulation, then palpation. Very seldom did participants use palpation alone. Conclusions: From the limited sample included in analyses, the Canadian physicians respondents seem to be treating HSP and associated PSS with variable strategies. Further research is required to align dosages, targets, and guidance strategies as they vary considerably.<\/jats:p>","DOI":"10.3390\/toxins18050228","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:04:36Z","timestamp":1778601876000},"page":"228","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Early Intervention of Hemiplegic Shoulder Pain in the Context of Post-Stroke Shoulder Spasticity: A Canadian Cross-Sectional Survey"],"prefix":"10.3390","volume":"18","author":[{"given":"Farris","family":"Kassam","sequence":"first","affiliation":[{"name":"Faculty of Medicine, University of British Columbia, Vancouver, BC V6T1Z3, Canada"},{"name":"Canadian Advances in Neuro-Orthopedics for Spasticity Consortium, Kingston, ON K7K1Z6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7937-6251","authenticated-orcid":false,"given":"Fraser","family":"MacRae","sequence":"additional","affiliation":[{"name":"Canadian Advances in Neuro-Orthopedics for Spasticity Consortium, Kingston, ON K7K1Z6, Canada"},{"name":"School of Physical Therapy, Western University, London, ON N6G1H1, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9337-8542","authenticated-orcid":false,"given":"Linden","family":"Lechner","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of British Columbia, Vancouver, BC V6T1Z3, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7013-7966","authenticated-orcid":false,"given":"Heather","family":"Dow","sequence":"additional","affiliation":[{"name":"Canadian Advances in Neuro-Orthopedics for Spasticity Consortium, Kingston, ON K7K1Z6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5994-2903","authenticated-orcid":false,"given":"\u00c8ve","family":"Boissonnault","sequence":"additional","affiliation":[{"name":"Canadian Advances in Neuro-Orthopedics for Spasticity Consortium, Kingston, ON K7K1Z6, Canada"},{"name":"Faculty of Medicine, University of Alberta, Edmonton, AB T6G2R7, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Huang","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of British Columbia, Vancouver, BC V6T1Z3, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8403-6988","authenticated-orcid":false,"given":"Paul","family":"Winston","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of British Columbia, Vancouver, BC V6T1Z3, Canada"},{"name":"Canadian Advances in Neuro-Orthopedics for Spasticity Consortium, Kingston, ON K7K1Z6, Canada"},{"name":"Department of Rehabilitation Medicine, Vancouver Island Health Authority, Victoria, BC V8R1J8, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/17474930241308142","article-title":"World Stroke Organization: Global Stroke Fact Sheet 2025","volume":"20","author":"Feigin","year":"2025","journal-title":"Int. J. Stroke"},{"key":"ref_2","first-page":"3238165","article-title":"Stroke in the 21st Century: A Snapshot of the Burden, Epidemiology, and Quality of Life","volume":"2018","author":"Donkor","year":"2018","journal-title":"Stroke Res. Treat."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Li, Y., Yang, S., Cui, L., Bao, Y., Gu, L., Pan, H., Wang, J., and Xie, Q. (2023). Prevalence, Risk Factor and Outcome in Middle-Aged and Elderly Population Affected by Hemiplegic Shoulder Pain: An Observational Study. Front. Neurol., 13.","DOI":"10.3389\/fneur.2022.1041263"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Zeng, H., Chen, J., Guo, Y., and Tan, S. (2021). Prevalence and Risk Factors for Spasticity After Stroke: A Systematic Review and Meta-Analysis. Front. Neurol., 11.","DOI":"10.3389\/fneur.2020.616097"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1007\/s00415-018-8759-1","article-title":"Defining Spasticity: A New Approach Considering Current Movement Disorders Terminology and Botulinum Toxin Therapy","volume":"265","author":"Dressler","year":"2018","journal-title":"J. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.rehab.2018.04.004","article-title":"Onset, Time Course and Prediction of Spasticity after Stroke or Traumatic Brain Injury","volume":"62","author":"Sunnerhagen","year":"2019","journal-title":"Ann. Phys. Rehabil. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1136\/jnnp.2004.035972","article-title":"Clinical Management of Spasticity","volume":"76","author":"Thompson","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/mus.20284","article-title":"Pathophysiology of Spastic Paresis. I: Paresis and Soft Tissue Changes","volume":"31","author":"Gracies","year":"2005","journal-title":"Muscle Nerve"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1747-4949.2010.00539.x","article-title":"Poststroke Chronic Disease Management: Towards Improved Identification and Interventions for Poststroke Spasticity-Related Complications","volume":"6","author":"Brainin","year":"2011","journal-title":"Int. J. Stroke"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1212\/WNL.0b013e3182764c86","article-title":"Poststroke Spasticity: Sequelae and Burden on Stroke Survivors and Caregivers","volume":"80","author":"Zorowitz","year":"2013","journal-title":"Neurology"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Hoad, D., Ashford, S., Bavikatte, G., Farrell, R., Robertson, A., and Wissel, J. (2025). A Concise Practical Clinical Guide to Identifying Spasticity in Neurological Shoulder Dysfunction. Front. Neurol., 15.","DOI":"10.3389\/fneur.2024.1440955"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2217\/pmt-2018-0075","article-title":"Hemiplegic Shoulder Pain in People with Stroke: Present and the Future","volume":"9","author":"Kumar","year":"2019","journal-title":"Pain Manag."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Kassam, F., Lim, B., Afroz, S., Boissonnault, \u00c8., Reebye, R., Finlayson, H., and Winston, P. (2023). Canadian Physicians\u2019 Use of Intramuscular Botulinum Toxin Injections for Shoulder Spasticity: A National Cross-Sectional Survey. Toxins, 15.","DOI":"10.3390\/toxins15010058"},{"key":"ref_14","unstructured":"Canadian Medical Association (2026, February 07). Physical Medicine and Rehabilitation Profile-CMA. Physical Medicine and Rehabilitation Profile. Available online: https:\/\/www.cma.ca\/sites\/default\/files\/2019-01\/physical-med-rehab-e.pdf."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1080\/09638288.2017.1400596","article-title":"A Survey of the Current Practice of Intramuscular Botulinum Toxin Injections for Hemiplegic Shoulder Pain in the UK","volume":"41","author":"Holmes","year":"2019","journal-title":"Disabil. Rehabil."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Li, S., Woo, J., and Mas, M.F. (2021). Early Use of Phenol Neurolysis Likely Reduces the Total Amount of Botulinum Toxin in Management of Post-Stroke Spasticity. Front. Rehabil. Sci., 2.","DOI":"10.3389\/fresc.2021.729178"},{"key":"ref_17","first-page":"100353","article-title":"Canadian Physicians\u2019 Use of Ultrasound in Spasticity Treatment: A National Cross-Sectional Survey","volume":"6","author":"MacRae","year":"2024","journal-title":"Arch. Rehabil. Res. Clin. Transl."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Fitterer, J., Picelli, A., and Winston, P. (2021). A Novel Approach to New-Onset Hemiplegic Shoulder Pain with Decreased Range of Motion Using Targeted Diagnostic Nerve Blocks: The ViVe Algorithm. Front. Neurol., 12.","DOI":"10.3389\/fneur.2021.668370"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1468-1331.2010.03129.x","article-title":"Botulinum Toxin Assessment, Intervention and after-Care for Upper Limb Hypertonicity in Adults: International Consensus Statement","volume":"17","author":"Sheean","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.2340\/16501977-0885","article-title":"Investigating Muscle Selection for Botulinum Toxin-A Injections in Adults with Post-Stroke Upper Limb Spasticity","volume":"43","author":"Baguley","year":"2011","journal-title":"J. Rehabil. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2340\/16501977-0120","article-title":"Associated Reactions after Stroke: A Randomized Controlled Trial of the Effect of Botulinum Toxin Type A","volume":"40","author":"Bhakta","year":"2008","journal-title":"Acta Derm. Venereol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/j.apmr.2019.01.016","article-title":"Effectiveness of Botulinum Toxin Treatment for Upper Limb Spasticity Poststroke Over Different ICF Domains: A Systematic Review and Meta-Analysis","volume":"100","author":"Andringa","year":"2019","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/01.phm.0000223216.50068.bc","article-title":"Effects of Botulinum Toxin-A on Gait Velocity, Step Length, and Base of Support of Patients with Dynamic Equinovarus Foot","volume":"85","author":"Cioni","year":"2006","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1212\/WNL.0000000000004687","article-title":"Efficacy and Safety of abobotulinumtoxinA in Spastic Lower Limb: Randomized Trial and Extension","volume":"89","author":"Gracies","year":"2017","journal-title":"Neurology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/j.rehab.2018.05.147","article-title":"Relief of Spasticity-Related Pain with Botulinum Neurotoxin-A (Bont-A) in Real Life Practice. Post-Hoc Analysis from a Large International Cohort Series","volume":"61","author":"Jacinto","year":"2018","journal-title":"Ann. Phys. Rehabil. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.apmr.2019.08.052","article-title":"OnabotulinumtoxinA Treatment in Adults with Spasticity Reduces Caregiver Burden: Results from the ASPIRE Study","volume":"100","author":"Wittenberg","year":"2019","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1177\/1747493019897847","article-title":"Canadian Stroke Best Practice Recommendations: Rehabilitation, Recovery, and Community Participation following Stroke. Part Two: Transitions and Community Participation Following Stroke","volume":"15","author":"Mountain","year":"2020","journal-title":"Int. J. Stroke"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/PHM.0000000000002802","article-title":"Canadian Stroke Best Practice Recommendations","volume":"105","author":"Nelson","year":"2026","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Baricich, A., Wein, T., Cinone, N., Bertoni, M., Picelli, A., Chisari, C., Molteni, F., and Santamato, A. (2021). BoNT-A for Post-Stroke Spasticity: Guidance on Unmet Clinical Needs from a Delphi Panel Approach. Toxins, 13.","DOI":"10.3390\/toxins13040236"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s00415-010-5463-1","article-title":"Early Development of Spasticity Following Stroke: A Prospective, Observational Trial","volume":"257","author":"Wissel","year":"2010","journal-title":"J. Neurol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Picelli, A., Santamato, A., Cosma, M., Baricich, A., Chisari, C., Millevolte, M., Prete, C.D., Mazz\u00f9, I., Girardi, P., and Smania, N. (2021). Early Botulinum Toxin Type A Injection for Post-Stroke Spasticity: A Longitudinal Cohort Study. Toxins, 13.","DOI":"10.3390\/toxins13060374"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1751-5823.2010.00112.x","article-title":"Selection Bias in Web Surveys","volume":"78","author":"Bethlehem","year":"2010","journal-title":"Int. Stat. Rev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1108\/10662240510590360","article-title":"The Value of Online Surveys","volume":"15","author":"Evans","year":"2005","journal-title":"Internet Res."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/18\/5\/228\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T04:19:08Z","timestamp":1778732348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/18\/5\/228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["toxins18050228"],"URL":"https:\/\/doi.org\/10.3390\/toxins18050228","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]}}}